Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-26 · accession 0001831218-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-26 | OLMA | Bohen Sean | Pres, CEO, Dir | G - Gift | $0.00 | -8,500 | 237.7K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-26 | G | D | 8,500 | $0.00 | 237,650 | D | — | — | (F2) Includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. |